Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-face comparison of glycolic acid versus salicylic acid peels for acne vulgaris
ACTRN12625001366448Phase 3Not yet recruiting
- Sponsor
- KRL Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Glycolic acid and Salvax in acne vulgaris, sponsored by KRL Hospital. Primary endpoint: Change in acne lesion count. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Glycolic acidSalvax
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ACTRN12625001366448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001366448.